NanoBone is a bone graft substitute consisting of nanocrystals of hydroxyapatite (HA) bioidentical to human bone, dispersed in an amorphous silica gel matrix (ASG).
Bioidentical to human bone
Forms a composite with ASG
NanoBone HA has 40x surface area of other HA-based bone grafts
Initiates Clotting Factor XII
Triggers angiogenesis and new bone formation
Rapidly replaced by an autologous organic matrix
Autologous organic matrix initiates cell-mediated bone formation and resorption
"I have complete confidence in arthrodesis achieved in a timely fashion with NanoBone with no threat of overgrowth or reactive airway marrow soft tissue associated with the biologics.”
Michael Schneier, MD,
Las Vegas, NV
FEATURED CASE STUDIES
FEATURED CLINICAL ABSTRACT SUMMARIES
Rosenthal, H. Evaluating a Nanocrystalline Hydroxyapatite Bone Graft Substitute for the Treatment of Benign Bone Tumors. The Internet Journal of Orthopedic Surgery. 2022 Volume 30 Number 1, 1-5.
Abedi, A. et al., Examination of the Role of Cells in Commercially Available Cellular Allografts in Spine Fusion. An in Vivo Animal Study, The Journal of Bone and Joint Surgery. 2020; 102(24):p e135.
Advancements in Bone Grafting in Foot & Ankle Surgery
ASPS: The Use of Advanced Biologics in Foot and Ankle Surgery
NanoBone for Spinal Surgery
NanoBone for Trauma & Sports Medicine
NanoBone for Foot & Ankle Surgery
NanoBone for Orthopedic Oncology
NanoBone Mechanism of Action
NanoBone QD in a Tibial Defect
NanoBone SBX in a Tibial Defect